Apple’s Record High… And Structure Therapeutics’ CEO On Weight Loss Drugs 6/11/24
CNBC's "Fast Money"
00:00
Market Analysis, Stock Evaluation, and Introduction to Instructure Therapeutics' Weight Loss Drug Venture
Discussion on recent game play, stock evaluations of Nvidia and KRE, market trends of mid-cap and small banks, banks clearing weak loans, and a detailed look into Instructure Therapeutics' approach to the obesity drug race with CEO Ray Stevens providing insights on the company's new data and market potential.
Play episode from 29:10
Transcript
